Sudden Severe SNHL in a 27-Year-Old - Management and Prognosis

Audiogram Interpretation

• Right ear: Near-normal (PTA ~11.6 dB HL, O symbols tracking close to 0 dB line)
• Left ear: Severe SNHL - X markers showing thresholds at 40-80+ dB HL, worsening at high frequencies (downsloping/flat-to-sloping configuration)
• Weber: Lateralizes to the RIGHT (the better ear) - confirms left-sided loss
• Rinne: Positive bilaterally - confirms sensorineural (not conductive) nature
• Provisional diagnosis (audiologist): Severe SNHL within the left ear

Immediate Management (Treat as Otologic Emergency)

Step 1: Urgent ENT Referral (already recommended on the form)

Step 2: Confirm Diagnosis and Exclude Secondary Causes

• MRI with gadolinium (IAM/posterior fossa) - to exclude retrocochlear pathology (vestibular schwannoma), mandatory per AAO-HNS guidelines. If MRI unavailable: auditory brainstem response (ABR).
• Routine labs are NOT recommended by guidelines, but reasonable to check: FBC, ESR, CRP, fasting glucose, lipids, TFT, coagulation screen, antiphospholipid antibodies (especially in a 27-year-old)
• In young patients: consider ANA, ANCA, anti-Ro/La if autoimmune suspected

Step 3: Treatment

• Protocol: Full dose for 4 days, then reduce by 10 mg every 2 days
• Add proton pump inhibitor (omeprazole 20 mg OD) to protect gastric mucosa
• Advise: take in the morning as a single dose
• At 27 years old with no contraindications, systemic steroids are well-tolerated

Per Cummings Otolaryngology: "Oral steroid therapy within the first 2 weeks has shown recovery rates up to 80%" (Cummings Otolaryngology, p. 3035)

• IT Dexamethasone (4-24 mg/mL) or IT Methylprednisolone (62.5 mg/mL), 0.3-0.5 mL per injection
• Recommended within 2-6 weeks of symptom onset (AAO-HNS KAS 10 - Recommended)
• Can be used as primary therapy if systemic steroids are contraindicated (e.g., diabetes, peptic ulcer, psychiatric illness)

• Can be offered in combination with steroids within 2 weeks of onset (initial therapy)
• Or as salvage within 1 month of onset
• Most effective in moderate-to-severe losses (≥60 dB) - which applies to this patient
• 2026 meta-analysis (PMID: 40747804) confirms benefit in SSNHL, particularly in severe cases

• Antivirals (acyclovir/valacyclovir) - not routinely recommended
• Vasodilators, rheologic agents (carbogen, dextran)
• Thrombolytics
• Antioxidants (evidence insufficient)

Step 4: Monitoring

• Repeat audiogram at 2 weeks (end of steroid course)
• If incomplete recovery: offer IT steroids as salvage
• Follow-up audiometry at 6 months (per AAO-HNS)
• If recovery is incomplete at 3 months: discuss hearing rehabilitation options

Prognosis for This Patient

• Young age (27 years) - age <40 carries better prognosis than older adults
• Unilateral loss - bilateral SSNHL has significantly worse prognosis
• Absence of vertigo (not mentioned - confirm clinically; if absent, this is favorable)

• Severe loss - the audiogram shows marked elevation in left ear thresholds (downsloping into the severe range). The more severe the loss, the worse the prognosis.
• Downsloping/flat configuration - upsloping or mid-frequency losses recover better than downsloping
• Reduced speech discrimination (if confirmed on speech audiometry) - carries poor prognosis

"Without treatment, 30-65% of patients experience complete or partial spontaneous recovery. Four variables affect prognosis: (1) severity of loss, (2) audiogram shape, (3) presence of vertigo, and (4) age." - Cummings Otolaryngology, p. 2939

"Most recovery occurs within the first 2 weeks after onset... Those who have not meaningfully recovered by 3 months are unlikely to do so." - Cummings Otolaryngology, p. 2939

• Mild losses: ~80% recovery rate
• Moderate losses: ~50-60% recovery
• Severe losses (this patient): recovery rates lower, approximately 30-50% with aggressive treatment; significant residual hearing loss is common
• Profound losses: <20% meaningful recovery

Rehabilitation if Persistent Loss

• Hearing aid (conventional or BAHA if severe enough)
• Cochlear implant - patients with SSNHL resulting in single-sided deafness are now recognized candidates for unilateral CI
• Tinnitus management (sound therapy, CBT if present)
• Audiologic rehabilitation

Summary Action Plan

1. Urgent ENT review (already recommended - within days, not weeks)
2. Start oral prednisone 60 mg/day immediately (do not wait for MRI)
3. MRI with gadolinium (IAM) - to exclude acoustic neuroma / retrocochlear pathology
4. Repeat audiogram in 2 weeks
5. If no response: IT dexamethasone as salvage therapy (within 2-6 weeks of onset)
6. Consider HBOT referral if available, especially given severe loss
7. Counsel on prognosis: guarded but treatable - young age is the key positive factor

Caroverine in This Case of Sudden Severe SNHL

What Is Caroverine?

Mechanism of Action - Why It Is Relevant to SNHL

1. Normal cochlear neurotransmission: Inner hair cells (IHCs) release glutamate onto spiral ganglion neuron (SGN) afferents via AMPA and NMDA receptors.
2. In sudden/ischemic SNHL: Cochlear ischemia, noise trauma, or viral insult causes massive glutamate release → over-activation of AMPA and NMDA receptors → excessive Ca²⁺ influx into SGNs → excitotoxic injury to the dendrites and synapses of the auditory nerve.
3. Caroverine's dual action:
   • Potent AMPA receptor antagonist (primary mechanism)
   • Weak NMDA receptor antagonist (secondary)
   • Blocks glutamate-induced firing of afferent fibers of cochlear inner hair cells
   • Reduces mitochondrial free radical overproduction → protects IHC-SGN synapses

"Glutamatergic neurotoxicity is characterized by a mitochondrial overproduction of free oxygen radicals damaging lipid membranes and DNA structures of the postsynaptic neuron followed by the clinical symptoms of hearing loss and tinnitus." - Ehrenberger K, 2002 (PMID: 11885656)

Clinical Evidence in Sudden SNHL

• Enrolled patients with strictly unilateral severe sudden SNHL >70 dB HL (similar to this patient)
• Excluded spontaneous-recovery confounders by specifically targeting losses >70 dB (generally unfavorable prognosis)
• Treatment: IV caroverine 160 mg in 250 mL 0.9% NaCl, twice daily, infused at 2 mL/min within the first 2 weeks of onset
• Results: "Complete recovery for low and middle frequencies and good recovery for high frequencies" - a "highly significant therapeutic benefit in contrast to rheological and vasoactive drugs"

• Placebo-controlled blind study (n=60)
• IV caroverine up to 160 mg
• 63.3% of treated patients showed significant tinnitus reduction vs. 0% in placebo
• Relevant because tinnitus and acute SNHL share the same excitotoxic cochlear mechanism

• Guinea pig study: IV administration achieves therapeutic perilymph concentrations
• Round window membrane local application achieves much higher perilymph levels with lower systemic exposure - potentially safer and more efficacious route
• Effects on hearing are transient and fully reversible

Applicability to This 27-Year-Old

Dosing Protocol (Ehrenberger/Vienna Protocol)

• Route: IV infusion (NOT oral - poor cochlear bioavailability orally)
• Dose: 160 mg caroverine hydrochloride in 250 mL 0.9% NaCl
• Rate: 2 mL/min (slow infusion over ~2 hours)
• Frequency: Twice daily
• Duration: Typically 5-10 days (within first 2 weeks of onset)
• Timing: Must be administered within 2 weeks of onset for any benefit - identical to the steroid window

Position in the Treatment Algorithm for This Patient

FIRST LINE (evidence-based, guideline-supported):
  ├── Oral prednisone 1 mg/kg/day × 10-14 days  ← do this regardless
  └── +/- Intratympanic dexamethasone (if severe, or primary IT therapy)

ADJUNCT (where available, mechanistically sound):
  └── IV Caroverine 160 mg BD × 5-10 days  ← add if available in your country

SALVAGE (if no response at 2 weeks):
  ├── IT steroid injections
  └── Hyperbaric oxygen therapy

• Steroids: reduce endolymphatic/cochlear inflammation, vascular permeability, immune-mediated damage
• Caroverine: blocks excitotoxic glutamate cascade at the IHC-SGN synapse

Limitations and Honest Assessment

Bottom Line for This Case

• If you are practicing in Austria/Switzerland where caroverine is registered: it is reasonable to add IV caroverine to the standard corticosteroid regimen within the first 2 weeks, given the severe loss and favorable risk profile in a young patient.
• If practicing elsewhere (most of the world): caroverine is unavailable. Prioritize steroids + IT salvage + HBOT per AAO-HNS guidelines. Memantine is a partial structural alternative but targets NMDA only, not AMPA.
• The silence in recent literature (no new trials, no guideline adoption) means this therapy has not been validated at scale. Inform the patient accordingly.

Immediate Alcohol-Induced Headache (ICHD-3: 8.1.4.1)

Diagnostic Criteria (ICHD-3)

1. Any headache fulfilling criterion C
2. Alcohol has been ingested
3. Evidence of causation - all of:
   • Headache develops within 3 hours of alcohol ingestion
   • Headache resolves within 72 hours after cessation
   • Headache has at least one of:
     • Bilateral location
     • Pulsating quality
     • Aggravated by physical activity
4. Not better accounted for by another ICHD-3 diagnosis

Who Gets It?

• Much rarer than hangover headache (delayed type)
• Strongly associated with migraine - migraineurs are disproportionately affected
• Can occur after very small amounts of alcohol in susceptible individuals, particularly red wine
• The threshold is variable - the same person may tolerate alcohol on some days and not others, reflecting fluctuating brain excitability

"Alcohol can trigger a cluster headache within minutes of ingestion." - Bradley and Daroff's Neurology in Clinical Practice

"At least three-quarters of migraineurs can identify triggers of their migraine attacks... the susceptibility of the migraine brain to potential triggers fluctuates from day to day." - Bradley and Daroff's Neurology, p. 2475

Pathophysiology - Why Alcohol Causes Immediate Headache

Clinical Management

Acute Treatment

• NSAIDs (ibuprofen 400-600 mg, naproxen 500 mg) - preferred; address prostaglandin-mediated neurogenic inflammation
• Aspirin 900 mg - well-established in migraine and acute headache
• Paracetamol/acetaminophen 1000 mg - safer if GI concerns, but less effective than NSAIDs for this phenotype
• Hydration - oral fluids (water); alcohol causes mild diuresis but this is less relevant for the immediate type vs. hangover

• Triptans (sumatriptan 50-100 mg oral, or 6 mg SC) - if the headache fits migraine criteria; this is a pragmatic approach given shared CGRP/trigeminovascular mechanisms
• Antiemetics if nausea present: metoclopramide 10 mg or prochlorperazine 10 mg

• High-flow 100% oxygen (12-15 L/min via non-rebreather mask × 15-20 min) - first line
• Sumatriptan 6 mg SC or zolmitriptan nasal spray 5 mg - highly effective for cluster
• This is a strong red flag for underlying cluster headache disorder requiring prophylaxis

Emerging Option

• Anti-CGRP therapies (gepants: rimegepant, ubrogepant) - biologically plausible given CGRP is a central mediator; may be useful for acute treatment especially in those with contraindications to triptans. Evidence specifically for alcohol-induced headache is not yet established but is being studied.

Clinical Workup Considerations

• First occurrence of severe headache with alcohol: rule out subarachnoid hemorrhage (alcohol can unmask a ruptured AVM/aneurysm), RCVS (Reversible Cerebral Vasoconstriction Syndrome - alcohol is a known trigger)
• Thunderclap onset (reaches maximum within seconds): urgent CT head ± LP regardless of alcohol context
• Neurological signs: focal deficit, altered consciousness, neck stiffness - investigate emergently
• Progressive pattern: headaches worsening with each alcohol exposure - reassess

"Alcohol can trigger a cluster headache within minutes of ingestion. If bending, lifting, coughing, or Valsalva maneuver brings on a headache, an intracranial lesion, especially one involving the posterior fossa, must be considered." - Bradley and Daroff's Neurology, p. 2510

Prevention and Long-Term Advice

Red Flag Summary

Unilateral Headache + Earache Within 30 Minutes of Alcohol

• Unilateral location
• Onset within 30 minutes of alcohol ingestion
• Ipsilateral ear pain

Why This Points to Cluster Headache

"During the period of freedom from pain, alcohol, which commonly precipitates headaches, no longer has the capacity to do so." - Adams and Victor's Principles of Neurology, 12th Ed., p. 201

"Alcohol can trigger a cluster headache within minutes of ingestion." - Bradley and Daroff's Neurology, p. 2510

"Cluster headache is associated with ipsilateral symptoms of cranial parasympathetic autonomic activation: conjunctival injection or lacrimation, aural fullness, rhinorrhea or nasal congestion, or cranial sympathetic dysfunction." - Harrison's 22nd Ed.

Diagnosis: ICHD-3 Criteria for Cluster Headache

• Other ipsilateral features during the attack: eye redness/tearing, drooping eyelid (ptosis), runny/blocked nose, facial flushing/sweating, miosis
• Restlessness/agitation during attacks (pacing, rocking - characteristic of cluster; migraineurs prefer stillness)
• Time of attacks: often nocturnal, 1-2 hours after sleep onset ("alarm clock headache")
• Cluster period: are attacks occurring daily for weeks, then a remission for months?
• Previous similar episodes in past years

Differential Diagnosis

"Cases of paroxysmal pain behind the eye or nose... associated with blocking of the nostril or lacrimation... probably represent variants of cluster headache... They are important because of the frequency of underlying intracranial lesions." - Adams and Victor's, p. 201

Mandatory Workup at First Presentation

• Ear: look for vesicles (Ramsay Hunt), otoscopy, tympanic membrane integrity
• Eye: conjunctival injection, ptosis, miosis, papilledema
• Cranial nerve exam: facial nerve function, trigeminal sensory testing
• Cervical spine: if cervicogenic headache is suspected

Management

Acute Attack Treatment (rapid onset essential - attacks peak in 5-10 min)

"Cluster headache attacks peak rapidly, and thus a treatment with rapid onset is required... Sumatriptan 6 mg SC is rapid in onset and will usually shorten an attack to 10–15 min." - Harrison's 22nd Ed.

Short-Term Preventive (bridge therapy to cover a cluster bout)

Long-Term Preventive (for chronic cluster or prolonged bouts)

Trigger Avoidance

• Complete alcohol abstinence during an active cluster bout - this is both diagnostic and therapeutic. Even small amounts reliably trigger attacks during a bout; during remission the same patient can drink without triggering.
• Avoid other vasodilators: nitroglycerin, napping, strong odors (petroleum, cigarette smoke), extreme heat
• Sleep regulation - avoid excessive napping; REM sleep is a common attack trigger

Practical Summary for This Patient

1. Suspect cluster headache - the 30-minute alcohol trigger + unilateral headache + ear pain is characteristic
2. Obtain MRI brain with gadolinium before finalizing diagnosis
3. Examine the ear carefully - exclude Ramsay Hunt (herpes zoster oticus) as it causes both ear pain and ipsilateral headache
4. Ask about autonomic features (eye redness, tearing, ptosis, nasal congestion, facial sweating) to confirm TAC phenotype
5. Prescribe acute treatment: oxygen 15 L/min (if available at home) + sumatriptan 6 mg SC for attacks
6. Start prevention: prednisone bridge + verapamil (titrated with ECG monitoring)
7. Strict alcohol avoidance during the current bout
8. Refer to neurology/headache specialist